Send the following on WhatsApp
Continue to ChatPACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer - https://avesis.istanbul.edu.tr/yayin/cd266ef0-a499-4210-8f0c-6bf3096ca589/pacific-a-double-blind-placebo-controlled-phase-3-study-of-durvalumab-as-consolidation-therapy-after-chemoradiation-in-patients-with-locally-advanced-unresectable-non-small-cell-lung-cancer